ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.449,09
0,15%
S&P 500
6.118,71
0,53%
Dow Jones
44.565,07
0,00%
Euro vs US Dollar
1,04766
0,59%
Bitcoin
105.447,94
1,43%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. PTC Therapeutics Inc (PTCT) Börsenkurse

PTC Therapeutics Inc

PTC Therapeutics Inc (PTCT)

NASDAQ
45,08
0,00
(0,00%)
Geschlossen 24 Januar 10:00PM
Verzögert um 15 Minuten
47,30
1,12
( 2,43% )
Vor Marktöffnung: 1:52PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
47,30
Gebot
44,00
Fragen
48,00
Volumen
502
0,00 Tagesbereich 0,00
23,58 52-Wochen-Bereich 54,16
Marktkapitalisierung
3,648B
Handelsende
46,18
Handelsbeginn
-
Letzte Trade
1
@
46.99
Letzter Handelszeitpunkt
13:52:55
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
722.092
Ausgegebene Aktien
77.125.143
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,68
Gewinn pro Aktie (EPS)
-8,12
Erlöse
1,07B
Nettogewinn
-626,6M

Über PTC Therapeutics Inc

PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is... PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.ptcbio.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
PTC Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PTCT. The last closing price for PTC Therapeutics was US$46,18. Over the last year, PTC Therapeutics shares have traded in a share price range of US$ 23,58 to US$ 54,16.

PTC Therapeutics currently has 77.125.143 shares in issue. The market capitalisation of PTC Therapeutics is US$3,56 billion. PTC Therapeutics has a price to earnings ratio (PE ratio) of -5.68.

PTCT Neueste Nachrichten

Weitere Nachrichten

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire WARREN, N.J., Jan. 13, 2025 WARREN, N.J., Jan. 13, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:...

13 Januar 2025
PR Newswire (US)

Form 8-K - Current report

13 Januar 2025
Edgar (US Regulatory)

PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference

PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference PR Newswire WARREN, N.J., Jan. 13, 2025 – Unaudited 2024 total...

13 Januar 2025
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

10 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Januar 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

10 Januar 2025
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
13.999.2126529669843.3147.542.1877410544.62965139CS
42.1154.6807568883545.18547.541.66558094944.40859683CS
127.3318.338754065539.9754.1638.2672209245.54568984CS
2613.8841.532016756433.4254.1629.01568434640.41253629CS
5218.9466.78420310328.3654.1623.5879656334.98800716CS
1569.0923.789583878638.2159.8417.5381808836.30162543CS
260-6.26-11.687826736453.5670.8217.5373291540.27049206CS

PTCT - Frequently Asked Questions (FAQ)

What is the current PTC Therapeutics share price?
The current share price of PTC Therapeutics is US$ 47,30
How many PTC Therapeutics shares are in issue?
PTC Therapeutics has 77.125.143 shares in issue
What is the market cap of PTC Therapeutics?
The market capitalisation of PTC Therapeutics is USD 3,56B
What is the 1 year trading range for PTC Therapeutics share price?
PTC Therapeutics has traded in the range of US$ 23,58 to US$ 54,16 during the past year
What is the PE ratio of PTC Therapeutics?
The price to earnings ratio of PTC Therapeutics is -5,68
What is the cash to sales ratio of PTC Therapeutics?
The cash to sales ratio of PTC Therapeutics is 3,34
What is the reporting currency for PTC Therapeutics?
PTC Therapeutics reports financial results in USD
What is the latest annual turnover for PTC Therapeutics?
The latest annual turnover of PTC Therapeutics is USD 1,07B
What is the latest annual profit for PTC Therapeutics?
The latest annual profit of PTC Therapeutics is USD -626,6M
What is the registered address of PTC Therapeutics?
The registered address for PTC Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the PTC Therapeutics website address?
The website address for PTC Therapeutics is www.ptcbio.com
Which industry sector does PTC Therapeutics operate in?
PTC Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
EVAXEvaxion Biotech AS
US$ 7,96
(118,68%)
11,41M
STBXStarBox Group Holdings Ltd
US$ 0,8929
(75,04%)
12,13M
IROHIron Horse Acquisition Corporation
US$ 16,45
(58,94%)
6
CRWSCrown Crafts Inc
US$ 6,99
(55,68%)
1
IZTCInvizyne Technologies Inc
US$ 18,00
(51,39%)
6
TOIIWOncology Institute Inc
US$ 0,0126
(-44,00%)
365
MDXGMiMedx Group Inc
US$ 5,11
(-43,41%)
128
IROQIF Bancorp Inc
US$ 14,01
(-41,89%)
3
LRFCLogan Ridge Finance Corporation
US$ 14,01
(-41,65%)
17
BCALCalifornia BanCorp
US$ 10,01
(-32,82%)
19
ACONAclarion Inc
US$ 0,0538
(24,54%)
75,67M
BTAIBioXcel Therapeutics Inc
US$ 0,3869
(1,87%)
16,5M
ATXIAvenue Therapeutics Inc
US$ 2,02
(9,78%)
14,9M
STBXStarBox Group Holdings Ltd
US$ 0,8929
(75,04%)
12,13M
EVAXEvaxion Biotech AS
US$ 7,96
(118,68%)
11,41M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
PTCT
PTC Therapeutics
LBNK
GLMRUSDT
Moonbeam
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten